Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Tax Provisions: 2011-2025

Historic Tax Provisions for Adma Biologics (ADMA) over the last 2 years, with Sep 2025 value amounting to $11.1 million.

  • Adma Biologics' Tax Provisions rose 1219.88% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.7 million, marking a year-over-year decrease of 1265.17%. This contributed to the annual value of -$72.0 million for FY2024, which is N/A change from last year.
  • Adma Biologics' Tax Provisions amounted to $11.1 million in Q3 2025, which was up 88.62% from $5.9 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Tax Provisions registered a high of $11.1 million during Q3 2025, and its lowest value of -$77.2 million during Q4 2024.
  • In the last 2 years, Adma Biologics' Tax Provisions had a median value of $3.8 million in 2024 and averaged -$6.9 million.
  • Data for Adma Biologics' Tax Provisions shows a peak YoY skyrocketed of 1,219.88% (in 2025) over the last 5 years.
  • Over the past 2 years, Adma Biologics' Tax Provisions (Quarterly) stood at -$77.2 million in 2024, then spiked by 1,219.88% to $11.1 million in 2025.
  • Its last three reported values are $11.1 million in Q3 2025, $5.9 million for Q2 2025, and $6.5 million during Q1 2025.